INVESTORS
2020-03-27MMMM D, YYYY

IR call: Sanofi expands collaboration with Translate Bio to develop mRNA COVID-19 vaccine

At a glance

Jean-Baptiste de Chatillon
2020-04-28MMMM D, YYYY

Annual General Meeting 2020: latest updates

Sanofi is assessing various options, in consultation with the French authorities, which would allow it to maintain its AGM on the planned date of April 28 while fully respecting the restrictions imposed by the French government to limit the spread of the coronavirus. Sanofi is confident it will find an appropriate pathway for the dividend to be paid irrespective of the various AGM options under review. Sanofi will keep its shareholders updated via the AGM 2020 page (click on "All information" below).

Sanofi is offering you the opportunity to get your convocation to the next Shareholders Meeting and exercise your voting-rights online.

Upcoming events

Annual Report on Form 20-F 2018

Annual Report on Form 20-F 2019

Paul Hudson
INVESTORS

Sanofi Conference Call

2020-02-24MMMM D, YYYY

In-depth reading

Scientist
INVESTOR PRESENTATIONS

Capital Markets Day

2019-12-10MMMM D, YYYY
2017 Integrated Report

2018 Integrated Report

All financial results going back to 2013
FINANCIAL RESULTS

All financial results going back to 2015

Contact the Investor Relations team

54 rue La Boétie
75008 Paris FRANCE
France +33 (0)1 53 77 45 45 • ir@sanofi.com
United States +1 908 981 5560

Individual shareholders

Direct access to Individual shareholders - Welcome to Sanofi

Access your dedicated section

Shareholder Handbook 2019

Two Asian women

Letter to shareholders December 2019

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK